ILIU
Interleukin Genetics, Inc.
Other OTC
People also watch:DDXSAPHBFPMIILNSPBIO
0.110.00 (3.81%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.10
Open0.10
Bid0.00 x
Ask0.00 x
52wk Range0.04 - 0.41
Day's Range0.10 - 0.11
Volume5,800
Avg Vol (3m)35,107
As of 10:50 AM EDT. Other OTC Delayed Price. Market open.
  • American City Business Journals2 months ago

    Waltham diagnostics firm Interleukin Genetics gets ready to relist on the Nasdaq

    On Friday, Interleukin Genetics (ILIU) submitted federal filings outlining plans to raise about $15 million through the sale of stock, enough to satisfy the capital requirements needed to list on the Nasdaq exchange. The company said shareholders supported a reverse split of between 1-for-5 and 1-for-40 in order to meet the $1 minimum stock price requirement required to list on the Nasdaq Capital Exchange. The company was delisted from the Nasdaq exchange in 2002, then eventually landed on the NYSE Amex exchange, where it was delisted in 2010.

  • Zacks Small Cap Research4 months ago

    ILIU: Making Progress on PerioPredict Adoption

    By Brian Marckx, CFA OTC:ILIU Q4 2015 : PerioPredict Adoption Still Slow, But Making Progress. Top-Notch Clinical Advisory Board Brought On Interleukin Genetics (OTC:ILIU) reported financial results for ...